e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing?
Kim Lucia, Tsao Ming Sound
Source:
Eur Respir J 2014; 44: 1011-1022
Journal Issue:
October
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kim Lucia, Tsao Ming Sound. Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing?. Eur Respir J 2014; 44: 1011-1022
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Modern staging in lung cancer: from the current multidisciplinary process to novel approaches
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019
Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019
Targeted therapies for lung cancer: how did the game begin?
Source: Breathe 2016; 12: 177-179
Year: 2016
Modern profiling of advanced lung cancer at the primary diagnosis and during therapy
Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer
Year: 2018
The clinical benefit of personalised medicine in lung cancer
Source: International Congress 2014 – Understanding the benefit of current personalised medicine platforms
Year: 2014
Precision medicine for lung cancer: new targeted treatments
Source: International Congress 2017 – Precision medicine approaches in lung cancer
Year: 2017
Modern molecular lung cancer diagnostics – how to use and interpret it wisely
Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy
Year: 2018
Eminence or evidence based ? – personalised diagnostic-therapeutic sequences in a molecular altered advanced NSCLC patient
Source: International Congress 2017 – GR2 Lung Cancer Grand Round
Year: 2017
Challenges in molecular testing in lung cancer patients with advanced disease
Source: International Congress 2016 – Lung cancer: latest developments in screening and patient management
Year: 2016
Slow-growing lung cancer as an emerging entity: from screening to clinical management
Source: Eur Respir J 2013; 42: 1706-1722
Year: 2013
Evolution in the diagnostic approach to lung cancer
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021
Lung cancer, noninvasive molecular treatment and monitoring
Source: International Congress 2016 – ERS-ALAT-SBPT-SEPAR-SPP joint session: Spanish and Portuguese Session II
Year: 2016
Is EBUS sampling adequate for molecular testing in patients with advanced NSCLC?
Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound
Year: 2020
New treatment concepts in stage IV non-small cell lung cancer: personalised multidisciplinary approaches
Source: Virtual Congress 2021 – Thoracic oncology
Year: 2021
PG1 Re-defining the role of chest physicians in lung cancer:ÿnew opportunities in diagnostics and therapy
Source: Milan 2017 - Educational material
Year: 2017
Advances in target therapy in lung cancer
Source: Eur Respir Rev 2015; 24: 23-29
Year: 2015
Advances in target therapy for lung cancer
Source: International Congress 2014 – Ceremony for the ERS Romain Pauwels Research Award 2014 - Clinical Year in Review I
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept